Navigation Links
Phase 2b Data Suggest ReVision's Oral Fenretinide (RT-101) Slows Lesion Growth, Preserves Vision and Reduces Incidence of Neovascularization in Geographic Atrophy Patients
Date:10/18/2010

nd induction of angiogenic mediators has been implicated in risk and progression of wet AMD. Fenretinide limits the delivery of retinol to the eye through reduction of serum RBP. This slows the accumulation of retinol-derived toxins in the retina, thereby slowing lesion growth. The anti-inflammatory and anti-angiogenic properties of fenretinide are thought to provide an additional therapeutic benefit against development of wet AMD.

About ReVision Therapeutics

ReVision Therapeutics Inc. is an ophthalmic biopharmaceutical company developing a novel small-molecule drug to slow the progression of the dry form of age-related macular degeneration (AMD) and prevent wet AMD. Fenretinide (RT-101), ReVision's lead drug candidate, showed a positive treatment effect for both slowing lesion growth in dry AMD and reducing the incidence of wet AMD in a Phase 2b clinical trial in patients with geographic atrophy, the most advanced form of dry AMD. The company plans to initiate a pivotal Phase 3 trial after discussion with the FDA. AMD is the leading cause of blindness in the elderly, and there are currently no treatments for the dry form of AMD, which accounts for 90 percent of patients with the disease. Dry AMD gradually destroys sharp, central vision. Most cases of wet AMD are preceded by dry AMD, and the onset of wet AMD can cause rapid blindness. ReVision was founded in 2010 with corporate headquarters in San Diego, California. For more information, visit www.revisiontherapeutics.com

Media Contact
Heidi Chokeir, Ph.D.
Russo Partners, LLC
(858)380-6584
heidi.chokeir@russopartnersllc.com




'/>"/>
SOURCE ReVision Therapeutics Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Kaiser Permanentes ALL/PHASE Initiative Wins 2010 Care Continuum Alliance Quality Impact Award for Greatest Impact on Health
2. BioSpecifics Technologies Corp. Announces Initiation of Global Phase 3 Trial of XIAFLEX® for Treatment of Peyronies Disease
3. Titan Pharmaceuticals Announces Journal of the American Medical Association Publication of Phase 3 Probuphine™ Data
4. Albireo Announces Positive Results in Patients With Chronic Idiopathic Constipation From a Phase IIb trial of A3309
5. DATATRAK Awarded Three Phase III Studies
6. BiondVax Begins Phase IIa Study for Universal Flu Vaccine
7. Auxilium Pharmaceuticals, Inc. Announces Initiation of XIAFLEX® Phase III Studies for Peyronies Disease
8. Obstetrics and Gynecology Publishes Data From Pivotal Phase 3 LYSTEDA Study
9. ISTA Pharmaceuticals Reports Positive Preliminary Results from its Phase 1/2 Clinical Study of Bepotastine Besilate Nasal Spray for the Treatment of Symptoms Associated with Seasonal Allergic Rhinitis
10. New Details Presented at the World Parkinson Congress on Neurologixs Successful Phase 2 Trial of Gene Therapy for Parkinsons Disease
11. Phase III Data Showing Improved Survival With Jevtana® (cabazitaxel) Injection in Second-Line Advanced Prostate Cancer Published in The Lancet
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/19/2014)... 19, 2014  As power morcellator lawsuits continue ... Liebhard LLP notes that women in need of ... number of options that do not involve the ... to a report published by The Wall Street ... include a mini-laparotomy and vaginal hysterectomy. Non-surgical options ...
(Date:8/19/2014)... Research and Markets has announced the ... by Technology, by Application & by Region- Global Trends & ... The demand for membranes is estimated to increase at ... $29.31 billion Membrane technology was first commercialized in ... filtration and kidney dialysis. In modern times, membranes find extensive ...
(Date:8/19/2014)... Va. , Aug. 19, 2014 Avizia, ... announced that it has closed an equity financing round ... and Middleland Capital. The new funding will be used ... With this financing round, Avizia welcomes Edward Kennedy ... board of directors. He joins Leonard Kurtzman , ...
Breaking Medicine Technology:As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation 2As Morcellator Lawsuits Mount, Bernstein Liebhard LLP Notes Report Detailing Alternatives to Uterine Morcellation 3Global Membranes (MF, RO, UF, Gas Separation, Dialysis, NF) Market - Forecasts to 2019 2Avizia Closes Funding Round 2
... June 30 If you have been eating Garlic to keep ... there is absolutely no scientific evidence that eating garlic actually keeps ... keeps them away. , , Spraying garlic extract on ... a product from Garlic Research Labs, Inc. is being used successfully ...
... Accumetrics, Inc. announces that it has reached the halfway mark ... GRAVITAS ( G auging R esponsiveness with A ... A nd S afety). The trial is ... actionable information for patients who are poor responders to clopidogrel ...
Cached Medicine Technology:Keep Mosquitoes and More Out of Your Yard with Garlic From Garlic Research Labs, Inc. 2Accumetrics, Inc. Announces GRAVITAS Trial 50 Percent Enrolled 2
(Date:8/20/2014)... August 20, 2014 The report ... Cars - A Global Analysis: by Geography - ... MarketsandMarkets, classifies and defines automotive airbag and seatbelt ... report highlights potential growth opportunities in the coming ... – market drivers, restrains, growth indicators, challenges, legislation ...
(Date:8/20/2014)... 2014 In a recent article published ... College London (UCL) study showed that dental experts from ... brushing teeth was the most effective. Analysis of 66 ... techniques were frequently recommended, but none were favored by ... Dentistry, experienced cosmetic dentist Dr. Patrick J. ...
(Date:8/20/2014)... August 20, 2014 Hope For The ... Hope® Celebration to be hosted in Washington, DC on ... Club. This signature event honors the courage of our ... the fallen. Proceeds from the Got Heart, Give Hope® ... nonprofit dedicated to restoring a sense of self, restoring ...
(Date:8/20/2014)... (PRWEB) August 20, 2014 No matter how ... count on a steady set of friends to be always ... it comes to the concept of making new friends ... various responsibilities ranging from taking care of one’s family to ... with talking to a new person just is not the ...
(Date:8/20/2014)... Ticketability.com has Theresa Caputo tickets ... The well-known medium has been thrilling many with her ... 19 cities, with tickets becoming available August 15. , ... are Albany, Baltimore, Trenton, Erie, Buffalo, Philadelphia, Charlotte, Houston, ... San Diego. The medium’s fans can obtain Theresa Caputo ...
Breaking Medicine News(10 mins):Health News:Automotive Airbag Market Worth $23.6 Billion and Automotive Seat Belt Market Worth $9.0 Billion by 2019 – New Report by MarketsandMarkets 2Health News:Automotive Airbag Market Worth $23.6 Billion and Automotive Seat Belt Market Worth $9.0 Billion by 2019 – New Report by MarketsandMarkets 3Health News:Automotive Airbag Market Worth $23.6 Billion and Automotive Seat Belt Market Worth $9.0 Billion by 2019 – New Report by MarketsandMarkets 4Health News:Ending Confusion About the Best Way to Brush Teeth 2Health News:Ending Confusion About the Best Way to Brush Teeth 3Health News:Hope For The Warriors Announces Got Heart, Give Hope Celebration in Washington, DC 2Health News:‘How to Make Friends as an Adult by Just Being Yourself: Becoming a “People Person” In Three Steps or Less’ Gives Tips for Making Friends During Adulthood - Vinamy 2Health News:Theresa Caputo Tour Tickets for Sale at Ticketability.com Cause a Buying Frenzy Among Customers Over Their Offering of Deeply Discounted Seats 2
... a new study, people with Down syndrome live twice as long ... a lower than average risk of developing many forms of cancer. ... week's Lancet was based on data collected from death certificates between ... average age at death for the 10,800 reported to have Down ...
... memory loss is often an indicator of Alzheimer's disease and is ... of controversy over the implications of mild cognitive decline the loss ... solving and planning.Some people think it is a normal part of ... while there is also the view that it's a disease in ...
... side of the brain helps people recognise themselves in ... Beth Israel Deaconess Medical Center in Boston report their ... study joins a growing body of evidence that demonstrates ... Studies of self-awareness may provide unique insights into consciousness ...
... to drink more to feel drunk than non-smoking drinkers – ... livers and hearts, a new study suggests.// ,The study ... are considered a good model for humans.Since alcohol abusers generally ... to get an expected level of intoxication, say the researchers ...
... a potential new treatment for people with severe cases of ... involves removing stem cells// from the patients’ blood, killing the ... then returning the healthy cells back to the body. The ... healthy immune system cells and the disease process can be ...
... People who take the cholesterol-lowering drugs called statins may ... 80%. Statins have been proved to offer// powerful protection ... The findings provide the strongest evidence to date that ... disease. ,An earlier, smaller study had suggested ...
Cached Medicine News:Health News:Down syndrome life anticipation doubles 2Health News:Right side of the brain helps in awareness 2
... Laser System is a solid state Holmium: ... in all areas of the urinary tract, ... , ,A variety of reusable fibers provide ... clinical versatility and outcomes. Standard 115V electrical ...
... offers increased bone surface area contact between ... management of nonunions in long bones., ,Grid-Like ... of Contact on Host Bone , ,The ... cathode offers increased surface area and a ...
... proud to offer one of ... market at only 188 grams! ... a superior flow rate with ... mechanisms. The complementing electrodes provide ...
Flowmate makes portable uroflowmetry easy, accurate and dignified. Flowmate has automatic start and stop as well as simple and straightforward reporting from its own printer....
Medicine Products: